{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:13:18Z","timestamp":1778577198176,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007271","name":"National Center for GM Crops","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG047986"],"award-info":[{"award-number":["AG047986"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK105588"],"award-info":[{"award-number":["DK105588"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bmc.2021.116347","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T19:00:44Z","timestamp":1628103644000},"page":"116347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Docking and mutagenesis studies lead to improved inhibitor development of ML355 for human platelet 12-lipoxygenase"],"prefix":"10.1016","volume":"46","author":[{"given":"Wan-Chen","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansari M.","family":"Aleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennyfer","family":"Tena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirella","family":"Rivera-Velazquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harman Singh","family":"Brah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarvind","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinee","family":"D'silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry L.","family":"Nadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chakrapani","family":"Kalyanaraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore","family":"Holman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"34","key":"10.1016\/j.bmc.2021.116347_b0005","doi-asserted-by":"crossref","first-page":"23679","DOI":"10.1074\/jbc.274.34.23679","article-title":"Lipoxygenases: Occurrence, Functions, Catalysis and Acquisition of Substrate","volume":"274","author":"Brash","year":"1999","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.bmc.2021.116347_b0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbrc.2005.08.238","article-title":"Structural biology of mammalian lipoxygenases: enzymatic consequences of targeted alterations of the protein structure","volume":"338","author":"Kuhn","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"3-4","key":"10.1016\/j.bmc.2021.116347_b0015","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10555-007-9098-3","article-title":"Lipoxygenase metabolism: roles in tumor progression and survival","volume":"26","author":"Pidgeon","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.bmc.2021.116347_b0020","doi-asserted-by":"crossref","unstructured":"Burkhart, J.M., et al., The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood, 2012. 120(15): p. e73-82.","DOI":"10.1182\/blood-2012-04-416594"},{"key":"10.1016\/j.bmc.2021.116347_b0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pharmthera.2018.10.010","article-title":"Role of the 12-lipoxygenase pathway in diabetes pathogenesis and complications","volume":"195","author":"Dobrian","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"09","key":"10.1016\/j.bmc.2021.116347_b0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1160\/TH13-01-0014","article-title":"12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivity","volume":"110","author":"Yeung","year":"2013","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.bmc.2021.116347_b0035","first-page":"17","article-title":"Circulating platelet aggregation in ischemic heart disease","volume":"38","author":"Ciko","year":"1981","journal-title":"Vojnosanitetski pregled. Military-medical and pharmaceutical review"},{"issue":"7","key":"10.1016\/j.bmc.2021.116347_b0040","first-page":"414","article-title":"Observations on platelet aggregation in patients with ischemic heart disease","volume":"65","author":"Chen","year":"1985","journal-title":"Zhonghua yi xue za zhi"},{"issue":"1","key":"10.1016\/j.bmc.2021.116347_b0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0021-9150(73)90139-1","article-title":"Adenosine diphosphate induced platelet aggregation in myocardial infarction and ischemic heart disease","volume":"17","author":"Dreyfuss","year":"1973","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.bmc.2021.116347_b0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.CIR.83.1.38","article-title":"Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study","volume":"83","author":"Elwood","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.bmc.2021.116347_b0055","doi-asserted-by":"crossref","unstructured":"Gormsen, J., et al., ADP-induced platelet aggregation in vitro in patients with ischemic heart disease and peripheral thromboatherosclerosis. Acta medica Scandinavica, 1977. 201(6): p. 509-13.","DOI":"10.1111\/j.0954-6820.1977.tb15738.x"},{"issue":"13","key":"10.1016\/j.bmc.2021.116347_b0060","first-page":"509","article-title":"Pharmacological inhibition of platelet aggregation in primary and secondary prevention of ischemic heart disease","volume":"34","author":"Gryglik","year":"1979","journal-title":"Pol Tyg Lek"},{"issue":"18","key":"10.1016\/j.bmc.2021.116347_b0065","first-page":"1659","article-title":"Treatment of ischemic heart disease with the platelet aggregation inhibitor clopidogrel","volume":"166","author":"Helo","year":"2004","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.bmc.2021.116347_b0070","first-page":"33","article-title":"Newer agents in antiplatelet therapy: a review","volume":"3","author":"Yeung","year":"2012","journal-title":"J Blood Med"},{"issue":"06","key":"10.1016\/j.bmc.2021.116347_b0075","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1160\/TH12-11-0793","article-title":"Transient heparin-induced platelet activation linked to generation of platelet 12-lipoxygenase. Findings from a randomised controlled trial","volume":"109","author":"McMahon","year":"2013","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.bmc.2021.116347_b0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/09537104.2013.783688","article-title":"Inhibition of 12-lipoxygenase reduces platelet activation and prevents their mitogenic function","volume":"25","author":"Svensson Holm","year":"2014","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.bmc.2021.116347_b0085","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1006\/bbrc.2000.3390","article-title":"Hinokitiol, a selective inhibitor of the platelet-type isozyme of arachidonate 12-lipoxygenase","volume":"275","author":"Suzuki","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"16","key":"10.1016\/j.bmc.2021.116347_b0090","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1021\/jm049872s","article-title":"Probing the activity differences of simple and complex brominated aryl compounds against 15-soybean, 15-human, and 12-human lipoxygenase","volume":"47","author":"Segraves","year":"2004","journal-title":"J Med Chem"},{"issue":"23","key":"10.1016\/j.bmc.2021.116347_b0095","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1016\/j.bmc.2007.07.036","article-title":"Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2","volume":"15","author":"Vasquez-Martinez","year":"2007","journal-title":"Bioorg Med Chem"},{"issue":"22","key":"10.1016\/j.bmc.2021.116347_b0100","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1016\/j.bmc.2007.08.015","article-title":"Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries","volume":"15","author":"Deschamps","year":"2007","journal-title":"Bioorg Med Chem"},{"issue":"15","key":"10.1016\/j.bmc.2021.116347_b0105","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1021\/jm2005089","article-title":"Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase","volume":"54","author":"Kenyon","year":"2011","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2021.116347_b0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1021\/jm4016476","article-title":"Synthesis and Structure-Activity Relationship Studies of 4-((2-Hydroxy-3-methoxybenzyl)amino)benzenesulfonamide Derivatives as Potent and Selective Inhibitors of 12-Lipoxygenase","volume":"57","author":"Luci","year":"2014","journal-title":"J Med Chem"},{"issue":"14","key":"10.1016\/j.bmc.2021.116347_b0115","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1182\/blood-2014-05-575878","article-title":"Platelet 12-LOX is essential for FcgammaRIIa-mediated platelet activation","volume":"124","author":"Yeung","year":"2014","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bmc.2021.116347_b0120","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1161\/ATVBAHA.117.309868","article-title":"First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis","volume":"37","author":"Adili","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.bmc.2021.116347_b0125","doi-asserted-by":"crossref","unstructured":"Ma, K., et al., 12-Lipoxygenase Inhibitor Improves Functions of Cytokine-Treated Human Islets and Type 2 Diabetic Islets. J Clin Endocrinol Metab, 2017. 102(8): p. 2789-2797.","DOI":"10.1210\/jc.2017-00267"},{"issue":"11","key":"10.1016\/j.bmc.2021.116347_b0130","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.tips.2017.08.001","article-title":"Targeting 12-Lipoxygenase as a Potential Novel Antiplatelet Therapy","volume":"38","author":"Tourdot","year":"2017","journal-title":"Trends Pharmacol Sci"},{"issue":"13-14","key":"10.1016\/j.bmc.2021.116347_b0135","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.phytochem.2009.05.008","article-title":"Lipoxygenases - Structure and reaction mechanism","volume":"70","author":"Andreou","year":"2009","journal-title":"Phytochemistry"},{"issue":"2","key":"10.1016\/j.bmc.2021.116347_b0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/np020462l","article-title":"Exploring sponge-derived terpenoids for their potency and selectivity against 12-human, 15-human, and 15-soybean lipoxygenases","volume":"66","author":"Amagata","year":"2003","journal-title":"J Nat Prod"},{"issue":"10","key":"10.1016\/j.bmc.2021.116347_b0145","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1021\/np900465e","article-title":"Using enzyme assays to evaluate the structure and bioactivity of sponge-derived meroterpenes","volume":"72","author":"Robinson","year":"2009","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2021.116347_b0150","doi-asserted-by":"crossref","unstructured":"Jameson, J.B., 2nd, et al., A high throughput screen identifies potent and selective inhibitors to human epithelial 15-lipoxygenase-2. PLoS One, 2014. 9(8): p. e104094.","DOI":"10.1371\/journal.pone.0104094"},{"issue":"27","key":"10.1016\/j.bmc.2021.116347_b0155","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1021\/bi401621d","article-title":"ATP allosterically activates the human 5-lipoxygenase molecular mechanism of arachidonic acid and 5(S)-hydroperoxy-6(E),8(Z),11(Z),14(Z)-eicosatetraenoic acid","volume":"53","author":"Smyrniotis","year":"2014","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.bmc.2021.116347_b0160","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1021\/acs.biochem.8b01167","article-title":"Probing the Electrostatic and Steric Requirements for Substrate Binding in Human Platelet-Type 12-Lipoxygenase","volume":"58","author":"Aleem","year":"2019","journal-title":"Biochemistry"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621003552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621003552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:29:47Z","timestamp":1778574587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621003552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":32,"alternative-id":["S0968089621003552"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116347","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Docking and mutagenesis studies lead to improved inhibitor development of ML355 for human platelet 12-lipoxygenase","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116347"}}